Pharma Mirror
OCTOBER 15, 2021
This filler-binder enablespharmaceutical and nutraceutical manufacturers to target consumers that have difficultyswallowing standard tablets. Effervescent powders and tabletsoffer a more convenient way to deliver medicines or dietary supplements. Forinstance, many patients have problems swallowing tablets.
Medical Xpress
MAY 12, 2023
AI analysis of their data determined that these patients spoke using more verbs and fewer nouns and fillers. The study was led by Professor Masahisa Katsuno and Dr. Katsunori Yokoi, Nagoya University Graduate School of Medicine, in collaboration with Aichi Prefectural University and Toyohashi University of Technology.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
AUGUST 18, 2023
Along with resolving site inspection issues that cost Regeneron a high-dose Eylea launch in June, the company has scored an FDA nod for Veopoz as the first treatment for the ultra-rare inherited im | Alongside a Friday approval for its ultra-rare disease medicine Veopoz, Regeneron now expects a high-dose Eyelea nod in the next few weeks after resolving (..)
pharmaphorum
MARCH 12, 2021
Several cases of immune thrombocytopenia – a disorder characterised by low levels of blood platelets that can lead to bruising and bleeding – were reported in the European Medicines Agency’s safety surveillance database.
Roots Analysis
JANUARY 3, 2024
Medical aesthetics is a growing area of modern medicine that focuses on improving the cosmetic appearance of an individual through various medical treatments. Afterwards, in 2003, the FDA approved Hyaluronic Acid Fillers (HA dermal fillers), bringing the much-anticipated innovation to all types of face and non-face augmentation products.
The Pharma Data
OCTOBER 22, 2021
Novartis blazoned moment that it has inked an original agreement to work its manufacturing capacity and capabilities to address the COVID-19 epidemic by expanding its support of the filler and finish of the Pfizer-BioNTech COVID-19 vaccine. This new agreement follows a first contract inked before this time.
Pharmacy Checkers
NOVEMBER 12, 2020
But the Canadian drug includes a different binder or filler as inactive ingredients. Kesselheim and Bollyky go on to propose and advocate a system of allowing the safe importation of high-quality foreign versions of FDA-approved drugs to tackle the price gouging on off-patent medicines. There’s a different inactive ingredient.
Expert insights. Personalized for you.
100 
Let's personalize your content